Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Cohen

Showing results (161-170 of 250) with videos related to

Pageof 25
Sort By:
Urologic Oncology|May 5, 2010
BCAN Think Tank session 1: Overview of risks for and causes of bladder cancerAlexandre R Zlotta, Samuel M Cohen, Colin Dinney, et al.
Nature Communications|September 17, 2021
Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profilesDenise A Cobb, Nathan Smith, Suyash Deodhar, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 28, 2012
Diuron-induced rat bladder epithelial cytotoxicityMitscheli S Da Rocha, Lora L Arnold, Karen L Pennington, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 12, 2007
Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazarSarah H Tannehill-Gregg, Thomas P Sanderson, Daniel Minnema, et al.
Toxicology and Applied Pharmacology|March 17, 2009
Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vitro: differences between human and mouseSatoko Kakiuchi-Kiyota, Joseph A Vetro, Shugo Suzuki, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 30, 2006
Subchronic urinary bladder effects of muraglitazar in male ratsTerry R Van Vleet, M Randy White, Thomas P Sanderson, et al.
Critical Reviews in Toxicology|January 20, 2004
A framework for human relevance analysis of information on carcinogenic modes of actionM E Bette Meek, John R Bucher, Samuel M Cohen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 13, 2018
Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancerBowen Qi, Ayrianne J Crawford, Nicholas E Wojtynek, et al.
Toxicologic Pathology|January 8, 2009
Inorganic arsenic-induced intramitochondrial granules in mouse urotheliumShugo Suzuki, Lora L Arnold, David Muirhead, et al.
Critical Reviews in Toxicology|April 10, 2025
Mode of action approach supports a lack of carcinogenic potential of six organic UV filtersSamuel M Cohen, Alan R Boobis, David Jacobson-Kram, et al.
Pageof 25

Showing results (161-170 of 250) with videos related to

Sort By:
Pageof 25
Urologic Oncology|May 5, 2010
BCAN Think Tank session 1: Overview of risks for and causes of bladder cancerAlexandre R Zlotta, Samuel M Cohen, Colin Dinney, et al.
Nature Communications|September 17, 2021
Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profilesDenise A Cobb, Nathan Smith, Suyash Deodhar, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 28, 2012
Diuron-induced rat bladder epithelial cytotoxicityMitscheli S Da Rocha, Lora L Arnold, Karen L Pennington, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 12, 2007
Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazarSarah H Tannehill-Gregg, Thomas P Sanderson, Daniel Minnema, et al.
Toxicology and Applied Pharmacology|March 17, 2009
Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vitro: differences between human and mouseSatoko Kakiuchi-Kiyota, Joseph A Vetro, Shugo Suzuki, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 30, 2006
Subchronic urinary bladder effects of muraglitazar in male ratsTerry R Van Vleet, M Randy White, Thomas P Sanderson, et al.
Critical Reviews in Toxicology|January 20, 2004
A framework for human relevance analysis of information on carcinogenic modes of actionM E Bette Meek, John R Bucher, Samuel M Cohen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 13, 2018
Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancerBowen Qi, Ayrianne J Crawford, Nicholas E Wojtynek, et al.
Toxicologic Pathology|January 8, 2009
Inorganic arsenic-induced intramitochondrial granules in mouse urotheliumShugo Suzuki, Lora L Arnold, David Muirhead, et al.
Critical Reviews in Toxicology|April 10, 2025
Mode of action approach supports a lack of carcinogenic potential of six organic UV filtersSamuel M Cohen, Alan R Boobis, David Jacobson-Kram, et al.
Pageof 25